— Know what they know.
Not Investment Advice

TYME NASDAQ

Tyme Technologies, Inc.
1W: +26.9% 1M: -6.7% 3M: +24.3% 1Y: -70.1% 3Y: -80.6% 5Y: -95.5%
$0.31
Last traded 2022-09-16 — delisted
NASDAQ · Healthcare · Biotechnology

Balance Sheet Trends

Total Assets
$88M -20.2% ▼
5Y CAGR: +52.4%
Total Liabilities
$8M -6.3% ▼
5Y CAGR: +19.0%
Shareholders Equity
$80M -21.3% ▼
5Y CAGR: +61.0%
Cash & Investments
$74M -30.8% ▼
5Y CAGR: +48.0%
Total Debt
$37K -50.8% ▼
Net Debt
-$14M +87.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$29M$14M$27M$108M$14M
Short-Term Investments$0$0$0$0$61M
Cash & ST Investments$29M$14M$27M$108M$74M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$2M$2M$1M$2M$5M
Total Current Assets$31M$16M$28M$110M$79M
Property, Plant & Equip.$3K$10K$155K$75K$38K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$9M
Other Non-Current Assets$0$1M$1M$531K$0
Total Non-Current Assets$3K$1M$1M$606K$9M
Total Assets$31M$18M$30M$110M$88M
— Liabilities —
Accounts Payable$0$0$0$0$0
Short-Term Debt$480K$597K$573K$35K$37K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$4M$6M$5M$6M$7M
Total Current Liabilities$5M$6M$6M$6M$7M
Long-Term Debt$0$0$0$41K$0
Other Non-Current Liab.$0$2M$5M$3M$546K
Total Non-Current Liabilities$0$2M$5M$3M$546K
Total Liabilities$5M$8M$10M$8M$8M
— Equity —
Common Stock$10K$10K$12K$17K$17K
Retained Earnings-$53M-$86M-$108M-$137M-$160M
Accumulated OCI-$18K-$27K-$32K$0-$544K
Total Stockholders Equity$26M$10M$19M$102M$80M
Total Liabilities & Equity$31M$18M$30M$110M$88M
— Key Metrics —
Total Debt$480K$597K$573K$76K$37K
Net Debt-$28M-$14M-$26M-$107M-$14M
Total Investments$0$0$0$0$70M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms